NewsHealth / April 7, 2016

Mumps Cases Increasing, Spread To Purdue Campus

Mumps Cases Increasing, Spread To Purdue CampusThere are 45 confirmed cases of mumps on college campuses and five probable cases.Purdue University, Butler University, Indiana University, mumps2016-04-07T00:00:00-04:00
Mumps Cases Increasing, Spread To Purdue Campus

As of the beginning of April, there have been 45 cases of mumps on Indiana college campuses. Purdue University is investigating five probable cases.

file photo

WEST LAFAYETTE -- As of the beginning of April, there have been 45 cases of mumps on Indiana college campuses.

State health department data says the largest mumps outbreaks have occurred at Indiana University and Butler University, who have reported 17 and 24 confirmed cases, respectively. IUPUI has seen four mumps cases since the beginning of this year.

The number of cases could be going up, too. Purdue announced Wednesday the university is investigating five confirmed or probable cases of the mumps virus on its West Lafayette campus.

Mugdha Golwalkar ,vaccine-preventable disease epidemiologist for the state health department, says spring break might have been a factor in the virus’s spread between campuses.

“The concern with travel and especially with spring break is you see people congregating in a lot of locations and mingling with people from a lot of different areas,” Golwalkar says.

All these schools require their students to receive an MMR vaccine, which protects against mumps. However, experts say even after two shots, the vaccine is not 100 percent effective for every person.

At WFYI, our goal is to cover stories that matter to you. Our reporting is rooted in facts. It considers all perspectives and is available to everyone. We don't have paywalls, but we do need support. So if unbiased, trusted journalism is important to you, please join us. Donate now.

 

 

Related News

Tyler Trent's Cells Lead To Groundbreaking Therapy
Indiana's Infant Mortality Rate Drops Lowest In Six Years
Eli Lilly Acquires Dermatology Pharmaceutical Company Dermira For $1.1 Billion